Joint Ventures and VIE's

12 Months Ended

Sep. 27, 2019

Equity Method Investments and Joint Ventures [Abstract]

Joint Ventures and VIEs

For consolidated joint ventures, the entire amount of the revenue recognized for services performed and the costs associated with these services, including the services provided by the other joint venture partners, are included in the Company's result of operations. Likewise, the entire amount of each of the assets and liabilities are included in the Company’s consolidated balance sheet. There are no consolidated VIEs that have debt or credit facilities. Summary financial information of consolidated VIEs is as follows (in millions):



	September 27, 2019		September 28, 2018
Current assets	$	192.6	$	161.9
Non-Current assets	—		0.3
Total assets	$	192.6	$	162.2
Current liabilities	$	138.5	$	85.7
Non-current liabilities	—		—
Total liabilities	$	138.5	$	85.7



	For the Years Ended
	September 27, 2019			September 28, 2018			September 29, 2017
Revenue	$	571.6		$	481.4		$	72.5
Direct cost of contracts	(526.7		)	(452.9		)	(71.8		)
Gross profit	$	44.9		$	28.5		$	0.7
Net earnings	$	45.2		$	28.4		$	0.7

Unconsolidated joint ventures are accounted for under the equity method or proportionate consolidation. Proportionate consolidation is used for joint ventures that include unincorporated legal entities and activities of the joint venture are construction-related. For those joint ventures accounted for under proportionate consolidation, only the Company’s pro rata share of assets, liabilities, revenue, and costs are included in the Company’s balance sheet and results of operations. For the proportionate consolidated VIEs, the carrying value of assets and liabilities was $61.1 million and $63.7 million as of September 27, 2019, respectively and $85.1 million and $75.9 million as of September 28, 2018, respectively. For those joint ventures accounted for under the equity method, the Company's investment balances for the joint venture is included in Other Noncurrent Assets: Miscellaneous on the balance sheet and the Company’s pro rata share of net income is included in revenue. In limited cases, there are basis differences between the equity in the joint venture and Jacobs' investment created when Jacobs purchased their share of the joint venture. These basis differences are amortized based on an internal allocation to underlying net assets, excluding allocations to goodwill. As of September 27, 2019, the Company’s equity method investments exceeded its share of venture net assets by $71.8 million. Our investments in equity method joint ventures on the Consolidated Balance Sheets as of September 27, 2019 and September 28, 2018 was a net asset of $157.9 million and $150.1 million, respectively. During the years ended September 27, 2019, September 28, 2018, and September 29, 2017, we recognized income from equity method joint ventures of $48.5 million, $47.9 million, and $38.1 million, respectively.

Summary financial information of unconsolidated joint ventures accounted for under the equity method, as derived from their unaudited financial statements, is as follows (in millions):



	September 27, 2019		September 28, 2018
Current assets	$	1,443.5	$	1,509.8
Non-Current assets	29.9		32.8
Total assets	$	1,473.4	$	1,542.6
Current liabilities	$	692.1	$	832.9
Non-current liabilities	473.6		664.0
Total liabilities	1,165.7		1,496.9
Joint ventures' equity	307.7		45.7
Total liabilities & joint venture equity	$	1,473.4	$	1,542.6



	For the Years Ended
	September 27, 2019			September 28, 2018			September 29, 2017
Revenue	$	3,533.1		$	3,165.0		$	1,853.7
Direct cost of contracts	(3,176.2		)	(2,902.5		)	(1,706.6		)
Gross profit	$	356.9		$	262.5		$	147.1
Net earnings	$	227.0		$	221.1		$	130.3

Accounts receivable from unconsolidated joint ventures accounted for under the equity method is $19.5 million and $11.1 million as of September 27, 2019 and September 28, 2018, respectively.

In July 2019, the Company sold 10% of its share of the equity method investment in Jasara, a Saudi Arabia joint venture. The Company sold the participation percentage for $1.2 million and recognized a $0.4 million gain on the sale.